European Journal of Cancer
Volume 43, Issue 13 , Pages 1905-1917 , September 2007

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer

  • S.J. Lord

      Affiliations

    • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 5, Building F, 88 Mallett Street, Locked Bag 77, Camperdown, New South Wales 2050, Australia
    • Corresponding Author InformationCorresponding author: Tel.: +61 2 9563 5322; fax: +61 2 9565 1863.
    • ,
  • W. Lei

      Affiliations

    • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 5, Building F, 88 Mallett Street, Locked Bag 77, Camperdown, New South Wales 2050, Australia
    • ,
  • P. Craft

      Affiliations

    • Medical Oncology Unit, The Canberra Hospital, Yamba Drive, Woden, Australian Capital Territory 2605, Australia
    • Academic Unit of Internal Medicine, Australian National University Medical School, Frank Fenner Building 42, Canberra Australian Capital Territory 0200, Australia
    • ,
  • J.N. Cawson

      Affiliations

    • St Vincents Hospital, University of Melbourne, 41 Victoria Parade, Fitzroy, Melbourne, Victoria 3065, Australia
    • ,
  • I. Morris

      Affiliations

    • Department of Diagnostic Imaging, Princess Margaret Hospital for Children and King Edward Memorial Hospital for Women, Subiaco, Western Australia 6008, Australia
    • ,
  • S. Walleser

      Affiliations

    • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 5, Building F, 88 Mallett Street, Locked Bag 77, Camperdown, New South Wales 2050, Australia
    • ,
  • A. Griffiths

      Affiliations

    • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 5, Building F, 88 Mallett Street, Locked Bag 77, Camperdown, New South Wales 2050, Australia
    • ,
  • S. Parker

      Affiliations

    • National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Level 5, Building F, 88 Mallett Street, Locked Bag 77, Camperdown, New South Wales 2050, Australia
    • ,
  • N. Houssami

      Affiliations

    • Screening and Test Evaluation Program (STEP), School of Public Health, The University of Sydney, A27, Sydney, New South Wales 2006, Australia

Received 1 May 2007 ,Revised 9 June 2007 ,Accepted 20 June 2007.

References 

  1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–1130
  2. Collaborative group on hormonal factors in breast cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389–99.
  3. Cuzick J, Forbes J, Edwards R, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet. 2002;360:817–824
  4. Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New Engl J Med. 1999;340:77–84
  5. Houssami N, Wilson R. Should women at high risk of breast cancer have screening magnetic resonance imaging (MRI)?. Breast. 2007;16:2–4
  6. Duffy SW, Tabar L, Smith RA. The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. CA: Cancer J Clin. 2002;52:68–71
  7. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347–360
  8. International Agency for Research on Cancer (IARC). Breast cancer screening. 7, IARC Handbooks of Cancer Prevention, Lyon: IARC Press; 2002.
  9. Liberman L. Breast cancer screening with MRI – what are the data for patients at high risk?. New Engl J Med. 2004;351:497–500
  10. Hamilton LJ, Evans AJ, Wilson AR, et al. Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clin Radiol. 2004;59:895–902
  11. Tilanus-Linthorst M, Verhoog L, Obdeijn IM, et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer. 2002;102:91–95
  12. National Collaborating Centre for Primary Care. Familial breast cancer: The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Partial update of NICE clinical guideline 14. <http://www.nice.org.uk/page.aspx?o=317667 [accessed 12.10.06].
  13. Saslow D, Boetes C, Burke W, et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA: Cancer J Clin. 2007;57:75–89
  14. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469–8476
  15. MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769–78.
  16. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898–1905
  17. Sardanelli F, Podo F, D’Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology. 2007;242:698–715
  18. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. J Am Med Assoc. 2004;292:1317–1325
  19. Irwig L, Houssami N, van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer. 2004;90:2118–2122
  20. National Breast Cancer Centre (NBCC). Magnetic resonance imaging for the early detection of breast cancer in women at high risk: a systematic review of the evidence. Camperdown: NBCC; 2006.
  21. Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25
  22. Zamora J, Muriel A, Abraira V. Meta_DiSc for Windows: a software package for the meta-analysis of diagnostic tests. <www.hrc.es/investigacion/metadisc.html> [accessed 03.02.07].
  23. Egger M, Davey Smith G, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed.. London: BMJ Publishing Group; 2001;
  24. Ganott MA, Sumkin JH, King JL, et al. Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer?. Radiology. 2006;238:793–800
  25. Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer. BMJ. 2006;332:678–679
  26. Kriege M, Brekelmans CTM, Boetes C, et al. Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition. Obstet Gynecol Surv. 2005;60:107–109
  27. Kriege M, Brekelmans CT, Boetes C, et al. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer. 2006;106:2318–2326
  28. Plevritis SK, Kurian AW, Sigal BM, et al. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. JAMA. 2006;295:2374–2384
  29. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138:W1–W12
  30. The Medical Services Advisory Committee. Breast magnetic resonance imaging, MSAC Application 1098. Canberra: Commonwealth of Australia; 2007.

PII: S0959-8049(07)00484-4

doi: 10.1016/j.ejca.2007.06.007

European Journal of Cancer
Volume 43, Issue 13 , Pages 1905-1917 , September 2007

Article Tools